Hemoglobinopathies in North Africa: A review

Hemoglobin

Volumn 34, Issue 1, 2010, Pages 1-23

  Khelil, Amel Haj ^a   Denden, Sabri ^a   Leban, Nadia ^a   Daimi, Houria ^a   Lakhdhar, Ramzi ^a   Lefranc, Grard ^b   Ben Chibani, Jemni ^a   Perrin, Pascale ^c  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b CNRS and University Montpellier II   (France)

^c CNRS   (France)

Author keywords

Haplotype; Hemoglobinopathies; Mutation; Sickle cell disease; Thalassemia

Indexed keywords

BETA GLOBIN; HEMOGLOBIN;

CHROMATOGRAPHY; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA POLYMORPHISM; DNA SEQUENCE; ELECTROPHORESIS; GENE MUTATION; GENETIC COUNSELING; HAPLOTYPE; HEMOGLOBINOPATHY; HUMAN; ISOELECTRIC FOCUSING; MORBIDITY; NORTH AFRICA; PHENOTYPE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRENATAL DIAGNOSIS; REVIEW; SICKLE CELL ANEMIA; SINGLE STRAND CONFORMATION POLYMORPHISM; THALASSEMIA;

AFRICA, NORTHERN; ANEMIA, HEMOLYTIC; HEMOGLOBINOPATHIES; HEMOGLOBINS; HUMANS;

EID: 76449106784     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630260903571286     Document Type: Review

References (104)

1. Weatherall DJ, Clegg JB. The Thalassaemia Syndromes, 3rd ed. Oxford: Blackwell Scientific; 1981.
2. Hardison RC, Chui DHK, Giardine B, et al. HbVar: a relational database of human hemoglobin variants and thalassemia mutations at the globin gene server. Hum Mutat. 2002;19(3):225-1223 (http://globin.cse.psu.edu).
3. Patrinos GP, Giardine B, Riemer C, et al. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res. 2004;32(Database issue):D537-D541 (http://globin.cse.psu.edu).
4. Kaplan JC, Delpech M. Génétique moléculaire de quelques maladies constitutionnelles. Biologie Moléculaire et Médecine. Paris: Flammarion, Médecine-Sciences. 1989:273-338.
5. Gγ. Br J Haematol. 1996;95(1): 67-72.
6. Flint J, Hill AVS, Bowden DK, Oppenheimer SJ. High frequencies of thalassemia are the result of natural selection by malaria. Nature. 1986;321(6072):744-750.
7. Galactéros F. Drépanocytose. Physiopathologie et diagnostic. Rev Prat. 1995;45(3):351-361.
8. Fattoum S. Hemoglobinopathies in Tunisia. An updated review of the epidemiologic and molecular data. Tunis Med. 2006;84(11):687-696.
9. Fawzi ZO, Al Hilali A, Fakhroo N, Al Bin Ali A, Al Mansour S. Distribution of Hemoglobinopathies and Thalassemias in Qatari Nationals Seen at Hamad Hospital in Qatar. Qatar Med J. 2003;12(1): 20-24.
10. Benkirane Agoumi N, Sebar A. Les hémoglobinopathies au Maroc. Arch Pédiatr. 2003;10(7):648-657.
11. Rosa J, Wajcman H, Blouquit Y. Hémoglobine. Encycl Méd Chir, Hématologie. France: Editions Techniques. 1993;14 (13000-S-10).
12. Babiker MM, Bachir N, Sarsour N. Prevalence of thalassaemia in schoolchildren in north-eastern Badia, Jordan. East Mediterr Health J. 1999;5(6):1165-1170.
13. Agouti I, Badens C, Abouyoub A, et al. Genotypic correlation between six common b-thalassemia mutations and the XmnI polymorphism in the Moroccan population. Hemoglobin. 2007;31(2): 141-149.
14. Fuchaoren S, Winichagoon P. Hemoglobinopathies in Southeast Asia. Hemoglobin. 1987;11(1): 65-88.
15. Siala H, Ouali F, Messaoud T, Bibi A, Fattoum S. α-Thalassaemia in Tunisia: some epidemiological and molecular data. J Genet. 2008;87(3):229-234.
16. Williams TN, Mailand K, Ganczakowski M, et al. Red blood cell phenotypes in a+ thalassaemias from early childhood to maturity. Br J Haematol. 1996;95(2):266-272.
17. Favier R, Ozsahin H, Laire V, Douay L. Apport du laboratoire dans le dépistage et le diagnostic des hémoglobinopathies en milieu pédiatrique. Rev Fr Lab. 1993;248:53-62.
18. Wilson JB, Headlee ME, Huisman THJ. A new high-performance liquid chromatography procedure for the separation and quantitation of various hemoglobin variants in adults and new born babies. J Lab Clin Med. 1983;102(2):174-186.
19. Siguret V, Andreux J-P. Diagnostic biologique des hé moglobinopathies par analyse du phénotype. Ann Biol Clin. 1997;55(2):103-112.
20. Maier-Redelsperger M, Girot R. Diagnostic des maladies de l'hémoglobine. Les Feuilles de Biologie. 1989;30:29-38.
21. Chibani J, Gritli E, Khelif A, Ben Ahmed S. Hémoglobinopathies en Tunisie centarle: les premiers pas du conseil génétique. Nouv Rev Fr Hématol. 1986;28(4):231-233.
22. Frikha M, Fakhfakh F, Mseddi S, et al. Hemoglobin bS haplotype in the Kebili region (southern Tunisia). Transfus Clin Biol. 1998;5(2):166-172.
23. Sassi R, Hmida S, Kaabi H, et al. Prevalence of C282Y and H63D mutations in the haemochromatosis (HFE) gene in Tunisian population. Ann Genet. 2004;47(4):325-330.
24. Hphα in the same Algerian family. Hum Mutat. 1995;5(2):182-183.
25. Bennani C, Tamouza R, Rouabhi F, et al. The spectrum of b-thalassaemia in Algeria: possible origins of the molecular heterogeneity and a tentative diagnostic strategy. Br J Haematol. 1993;84(2): 335-337.
26. Rouabhi F, Lapoumeroulie C, Amselem S, et al. DNA haplotype distribution in Algerian b thalassemia patients: an extended evaluation by family studies and representative molecular characterization. Hum Genet. 1988;79(4):373-376.
27. Fattoum S, Guemira F, Oner C, Li HW, Kutlar F, Huisman THJ. β-Thalassemia, Hb S-β-thalassemia and sickle cell anemia among Tunisians. Hemoglobin. 1991;15(1):11-21.
28. Chebil-Laradi S, Pousse H, Khelif A, et al. Screening of hemoglobinopathies and molecular analysis of b-thalassemia in Central Tunisia. Arch Pediatr. 1994;1(12):1100-1105.
29. Chouk I, Daoud BB, Mellouli F, et al. Contribution to the description of the b-thalassemia spectrum in Tunisia and the origin of mutation diversity. Hemoglobin. 2004;28(3):189-195.
30. Abdennebi M, Messaoud T, Zouari F, Fattoum S. Prenatal diagnosis of sickle cell anemia. Tunis Med. 1994;72(11):601-606.
31. Zorai A, Abbes S, Préhu C, et al. Hb H disease among Tunisians: molecular characterization of a-thalassemia determinants and hematological findings. Hemoglobin. 2003;27(1):57-61.
32. Haj Khelil A, Laradi S, Miled A, Omar Tadmouri G, Ben Chibani J, Perrin P. Clinical and molecular aspects of haemoglobinopathies in Tunisia. Clin Chim Acta. 2004;340(1-2):127-137.
33. Fattoum S, Messaoud T, Bibi A. Molecular basis of b-thalassemia in the population of Tunisia. Hemoglobin. 2004;28(3):177-187.
34. Siala H, Fattoum S, Messaoud T, Ouali F, Gerard N, Krishnamoorthy R. A novel a-thalassemia nonsense mutation in codon 23 of the a2-globin gene (GAG→TAG) in a Tunisian family. Hemoglobin. 2004;28(3):249-254.
35. Bibi A, Messaoud T, Fattoum S. Haplotypes linked to three rare b-thalassemia mutations, originally reported in Tunisia. Hemoglobin. 2006;30(2):175-181.
36. Mellouli F, El Borgi W, Kaabi H, et al. HFE gene mutations in Tunisian major b-thalassemia and iron overload. Transfus Clin Biol. 2006;13(6):353-357.
37. Regaya F, Oussaief L, Bejaoui M, Karoui M, Zili M, Khelifa R. Parvovirus B19 infection in Tunisian patients with sickle-cell anemia and acute erythroblastopenia. BMC Infect Dis. 2007;25(7):123-129.
38. Bouhass R, Aguercif M, Trabuchet G, Godet J. A new mutation at IVS1 nt 2(T→A), in b-thalassemia from Algeria. Blood. 1990;76(5):1054-1055.
39. Bienvenu T, Sebillon P, Labie D, Kaplan JC, Beldjord C. Rapid and direct detection of the most frequent Mediterranean b-thalassemic mutations by multiplex allele-specific enzymatic amplification. Hum Biol. 1992;64(1):107-113.
40. Périchon B, Ragusa A, Lapouméroulie C, et al. Inter-ethnic polymorphism of the b-globin gene locus control region (LCR) in sickle-cell anemia patients. Hum Genet. 1993;91(5):464-468.
41. Perrin P, Bouhassa R, Mselli L, et al. Diversity of SNP haplotypes associated with b-thalassemia mutations in Algeria: implications for their origin. Gene. 1998;213(1-2):169-177.
42. Agouti I, Badens C, Abouyoub A, Levy N, Bennani M. Molecular basis of b-thalassemia in Morocco: possible origins of the molecular heterogeneity. Genet Test. 2008;12(4):563-568.
43. Guemira F, Abbes S, Ducrocq R, Elion J, Fattoum S. Hb D Iran-b-thalassemia association in a Tunisian family. Ann Pediatr (Paris). 1992;39(6):369-374.
44. Laradi S, Haj Khelil A, Omri H, et al. Analyse moléculaire et diagnostic prénatal de la b-thalassemie: à propos de notre expérience en Tunisie centrale. Ann Biol Clin. 2000;58(4):459-460.
45. Moumni I, Zorai A, Daoued BB, et al. Hb A2-Pasteur-Tunis [d59(E3)Lys→Asn AAG→AAC]: A new d chain variant detected by DNA sequencing in a Tunisian carrier of the codon 39 (C→T) b0-thalassemia mutation. Hemoglobin. 2007;31(1):23-29.
46. Bennani C, Bouhass R, Perrin-Pécontal P, et al. Anthropological approach to the heterogeneity of b-thalassemia mutations in northern Africa. Hum Biol. 1994;66(3):369-382.
47. Boudrahem-Addour N, Zidani N, Carion N, Labie D, Belhani M, Beldjord C. Molecular heterogeneity of b-thalassemia in Algeria: how to face up to a major health problem. Hemoglobin. 2009;33(1): 24-36.
48. Lemsaddek W, Picanço I, Seuanes F, et al. The b-thalassemia mutation/haplotype distribution in the Moroccan population. Hemoglobin. 2004;28(1):25-37.
49. Jacquette A, Le Roux G, Lacombe C, Goossens M, Pissard S. Compound heterozygosity for two new mutations in the b-globin gene [codon 9 (+TA) and polyadenylation site (AATAAA→AAAAAA)] leads to thalassemia intermedia in a Tunisian patient. Hemoglobin. 2004;28(3):243-248.
50. Wajcman H, Belkhodja O, Labie D. Hb Setif: G1 (94) Asp→Tyr. A new chain hemoglobin variant with substitution of the residue involved in hydrogen bond between unlike subunits. FEBS Lett. 1972;27(2):298-300.
51. Chami B, Blouquit Y, Bardakdjian-Michau J, et al. Hemoglobin variants in North Africa. Hemoglobin. 1994;18(1):39-51.
52. Lefranc MP, Lefranc G, Farhat M, et al. Frequency of human Ag75 Thr globin chain in a population from Tunisia. Hum Genet. 1981;59(1):89-91.
53. 2104(G6)Arg→Ser found in Malta, Sicily and Tunisia. Hemoglobin. 1984;8(6):613-619.
54. 269(E13)Gly→Arg. A new b variant of elevated expression associated with a-thalassemia, found in a Moroccan woman. Hemoglobin. 1985;9(1):1-9.
55. Dahmane-Arbane M, Blouquit Y, Arous N, et al. Hemoglobin Boumerdès a237(C2) Pro→Argb2: a new variant of the a chain associated with Hemoglobin S in an Algerian family. Nouv Rev Fr Hematol. 1987;29(5):317-320.
56. Baklouti F, Baudin-Chich V, Kister J, et al. Increased oxygen affinity with normal heterotropic effects in Hemoglobin Loire [a88(F9)Ala→Ser]. Eur J Biochem. 1988;177(2):307-312.
57. Baklouti F, Francina A, Dorléac E, et al. Asymptomatic association of Hemoglobin Dunn (a6[A4]Asp→Asn) and Hemoglobin O-Arab (b121[GH4]Glu→Lys) in a Moroccan man. Am J Hematol. 1988;27(4):253-256.
58. Mrad A, Arous N, Kastally R, Blibech R, Rosa J, Galacteros F. First observation of Hb Montgomery [a48(CD6)Leu→Arg] in Tunisia. Hemoglobin. 1988;12(1):67-70.
59. 2124(H2)Pro→Ser], a new b chain variant identified by HPLC. Hemoglobin. 1988;12(1):23-30.
60. 240(C6)Arg→Lys] in association with b0-thalassemia in Tunisia. Am J Hematol. 1989;2(2):117-122.
61. 248(CD7)Leu→Pro, a mildly unstable variant found in an Arabian boy from Tunisia. Hemoglobin. 1992;16(4):267-273.
62. Guemira F, Abbes S, Ducrocq R, Elion J, Fattoum S. Hb D Iran-b-thalassemia association in a Tunisian family. Ann Pediatr (Paris). 1992;39(6):369-374.
63. Elion J, Belkhodja O, Wajcman H, Labie D. Two variants of Hemoglobin D in the Algerian population: Hemoglobin D Ouled Rabah 19(BI)Asn→Lys and Hemoglobin D Iran 22(Br)Glu→Gln. Biochim Biophys Acta. 1973;310(2):360-364.
64. Wajcman H, Kalmès G, Groff P, Promé D, Riou J, Galacteros F. Hb Melusine [a114(GH2)Pro→Ser]: a new neutral hemoglobin variant. Hemoglobin. 1993,17(5):397-405.
65. Darbellay R, Mach-Pascual S, Rose K, Graf J, Beris Ph. Haemoglobin Tunis-Bizerte: a new a1 globin 129 Leu→Pro unstable variant with thalassaemic phenotype. Br J Haematol. 1995;90(1): 71-76.
66. Wajcman H, Borensztajn K, Riou J, et al. Two new Gg chain variants: Hb F-Clamart [g17(A14)Lys→Asn] and Hb F-Ouled Rabah [g19(B1)Asn→Lys]. Hemoglobin. 2000;24(1):45-52.
67. Wajcman H, Drupt F, Henthorn JS, et al. Two new variants with the same substitution at position b122: Hb Bushey [b122(GH5)Phe→Leu] and Hb Casablanca [b65(E9)lys→Met;b122(GH5)Phe→Leu]. Hemoglobin. 2000;24(2):125-132.
68. 3.7. Hemoglobin. 2005;29(4):263-268.
69. Zorai A, Harteveld CL, Bakir A, van Delft P, Falfoul A, Dellagi K. Molecular spectrum of a-thalassemia in Tunisia: epidemiology and detection at birth. Hemoglobin. 2002;26(4):353-362.
70. Mesbah-Amroun H, Rouabhi F, Ducrocq R, Elion J. Molecular basis of a-thalassemia in Algeria. Hemoglobin. 2008;32(3):273-278.
71. Giordano PC, Zweegman S, Akkermans N, et al. The first case of Hb Groene Hart [a119(H2) Pro→Ser, CCT→TCT (a1)] homozygosity confirms that a thalassemia phenotype is associated with this abnormal hemoglobin variant. Hemoglobin. 2007;31(2):179-182.
72. Beldjord C, Lapouméroulie C, Baird ML, et al. D. Four new haplotypes observed in Algerian b-thalassemia patients. Hum Genet. 1983;65(2):204-206.
73. Eskandarani HA. Ethical concerns to the use of pre-implantation genetic diagnosis in the Gulf Cooperative Council States. Second Pan Arab Human Genetics Conference, Dubai, United Arab Emirates, 20-22 November 2007 (http//cags.org.ae/2ndpahgcabstracts.html).
74. Kan YW, Dozy AM. Polymorphism of DNA sequence adjacent to human b-globin structural gene: relationship to sickle mutation. Proc Natl Acad Sci USA. 1978;5(11):5631-5635.
75. Orkin SH, Little PF, Kazazian HH Jr, Boehm CD. Improved detection of the sickle mutation by DNA analysis: application to prenatal diagnosis. N Engl J Med. 1982;307(1):32-36.
76. Chibani J, Vidaud M, Duquesnoy P, et al. The peculiar spectrum of b-thalassemia genes in Tunisia. Hum Genet. 1988;78(2):190-192.
77. Pagnier J, Mears JG, Dunda-Belkhodja O, et al. Evidence for the multicentric origin of the sickle cell hemoglobin gene in Africa. Proc Natl Acad Sci USA. 1984;81(6):1771-1773.
78. Bloom M, Ed. Understanding Sickle Cell Disease. Understanding Health and Sickness Series. Jackon: University Press of Mississippi. 1995:33-34.
79. Henni T, Morlé F, Lopez B, Colonna P, Godet J. α-Thalassemia haplotypes in the Algerian population. Hum Genet. 1987;75(3):272-276.
80. Lemsaddek W, Picanço I, Seuanes F, et al. Spectrum of b thalassemia mutations and Hb F levels in the heterozygous Moroccan population. Am J Hematol. 2003;73(3):161-168.
81. Trabuchet G, Elion J, Baudot G, et al. Origin and spread of b-globin gene mutations in India, Africa and Mediterranea: analysis of the 5→-flanking and intragenic sequences of bS and bC genes. Hum Biol. 1991;63(3):241-252.
82. Abbes S, Fattoum S, Vidaud M, Goossens M, Rosa J. Sickle cell anemia in the Tunisian population: haplotyping and Hb F expression. Hemoglobin. 1991;15(1-2):1-9.
83. Flint J, Harding RM, Clegg JB, Boyce AJ. Why are some genetic diseases common? Distinguishing selection from other processes by molecular analysis of globin gene variants. Hum Genet. 1993; 91(2):91-117.
84. Tadmouri GO, Garguier N, Demont J, Perrin P, Basak AN. History and origin of b-thalassemia in Turkey: SNP haplotype diversity of the b globin genes. Hum Biol. 2001;73(5):661-674.
85. Inati A, Taher A, Bou Alawi W, et al. β-Globin gene cluster haplotypes and Hb F levels are not the only modulators of sickle cell disease in Lebanon. Eur J Haematol. 2003;70(2):79-83.
86. Zahed L, Demont J, Bouhass R, et al. Origin and history of the IVS-I-110 and codon 39 b-thalassemia mutations in the Lebanese population. Hum Biol. 2002;74(6):837-847.
87. Gγ expression. Blood. 1985;66(6):1463-1465.
88. Currat M, Trabuchet G, Rees D, et al. Molecular analysis of the b-globin gene cluster in the Niokholo Mandenka population reveals a recent orgin of the bS Senegal mutation. Am J Hum Genet. 2002;70(1):207-223.
89. Henderson S, Timbs A, McCarthy J, et al. Incidence of hemoglobinopathies in various populations - the impact of immigration. Clin Biochem. 2009;42(18):1745-1756.
90. Orkin SH, Goff SC, Nathan DG. Heterogeneity of DNA deletion in adb-thalassemia. J Clin Invest. 1981;67(3):878-884.
91. Tadmouri GO, Tüzman S, Ozçelik H, et al. Molecular and population genetic analyses of b-thalassemia in Turkey. Am J Hematol. 1998;57(3):215-220.
92. 227(B9)Ala→Ser): a new variety of b+-thalassemia intermedia associated with d0-thalassemia. Blood. 1986;67(4):957-961.
93. Tadmouri GO, Bilenoglu O, Kantarci S, Kayserili H, Perrin P, Basak AN. A rare mutation [IVS-I- 130 (G→A)] in a Turkish b-thalassemia major patient. Am J Hematol. 2000;63(4): 223-225.
94. Deidda G, Novelletto A, Hafez M, et al. A new b-thalassemia mutation produced by a single nucleotide substitution in the conserved dinucleotide sequence of the IVS-I consensus acceptor site (AG→AA). Hemoglobin. 1990;14(4):431-440.
95. Harteveld CL, Yavarian M, Zorai A, Quakkelaar ED, van Delft P, Giordano PC. Molecular spectrum of a-thalassemia in the Iranian population of Hormozgan: three novel point mutation defects. Am J Hematol. 2003;74(2):99-103.
96. Hellani A, Fadel E, El-Sadadi S, El-Sweilam H, El-Dawood A, Abu-Amero KK. Molecular spectrum of a-thalassemia mutations in microcytic hypochromic anemia patients from Saudi Arabia. Genet Test Mol Biomarkers. 2009;13(2):219-221.
97. Fichera M, Spalletta A, Fiorenza F, et al. Molecular basis of a-thalassemia in Sicily. Hum Genet. 1997;99(3):381-386.
98. Bernini LF. Geographic distribution of a-thalassemia. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, Eds. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management. Cambridge: Cambridge University Press. 2001;878-894.
99. Gilman JG, Huisman THJ. DNA sequence variation associated with elevated fetal Gg globin production. Blood. 1985;66(4):783-787.
100. Karimi M, Yarmohammadi H, Farjadian S, et al. β-Thalassemia intermedia from southern Iran: IVS-II-1 (G→A) is the prevalent thalassemia intermedia allele. Hemoglobin. 2002;26(2):147-154.
101. Birben E, Oner C, Oner R, et al. Severe b-thalassemia in frameshift codon 6 (-A) homozygotes: effects of haplotype on phenotype. Hemoglobin. 2001;25(4):441-445.
102. 0 avec phénotype "intermé diaire": un diagnostic rare auquel il faut penser. Ann Biol Clin. 2006;64(4):341-345.
103. Fullerton SM, Bond J, Schneider JA, et al. Polymorphism and divergence in the b-globin replication origin initiation region. Mol Biol Evol. 2000;17(1):179-188.
104. Haj Khelil A, Deguillien M, Morinière M, Ben Chibani J, Baklouti F. Cryptic splicing sites are differentially utilized in vivo. FEBS J. 2008;275(6):1150-1162.